Veratx

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.

Viridiantherapeutics

This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.

Alpine Immune Sciences

This biopharmaceutical company develops protein-based immunotherapies to treat autoimmune and inflammatory diseases for patients with conditions like kidney disease.

SenyaTx

This company develops antibody-based therapeutics targeting the LRG1 protein to treat patients with chronic vascular diseases, including nephrology, oncology, and ophthalmology conditions.

Veralox

This biotechnology company develops small-molecule therapeutics to treat inflammatory hematologic diseases and type 1 diabetes for patients with unmet medical needs.

Nionyx Bio

The company develops adeno-associated virus gene therapies for patients with genetic kidney diseases.

VTYX

This biopharmaceutical company develops oral small-molecule medicines for patients with autoimmune, inflammatory, cardiovascular and neurodegenerative diseases.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.